Serotiapine

Quick links to important sections

Serotiapine

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Serotiapine

Property Description
Active ingredient Quetiapine (Fumarate Salt)
Form Modified-release tablet (XR), Film-coated tablet
Pharmacological class Atypical Antipsychotic / Second-Generation Antipsychotic
Origin Synthetic (Dibenzothiazepine derivative)

What Type of Medicine is Serotiapine?

Serotiapine is a prescription-only medicine officially classified as an atypical antipsychotic, which places it within the broader group of second-generation antipsychotic and psychotropic agents. Containing the active substance quetiapine (usually prepared as the fumarate salt), this medicine is a synthetic compound derived from the dibenzothiazepine chemical structure. This classification differentiates it from older antipsychotic medications by its pleiotropic agent action and distinct receptor binding profile, which is clinically recognized for providing effective stabilization in complex psychiatric conditions.


Composition and Form: Understanding Quetiapine XR Tablets

The active ingredient in Serotiapine is Quetiapine fumarate, which is formulated as a single-ingredient product designed for oral administration. The primary form available is the modified-release tablet, often designated as an extended-release or XR tablet. This specific formulation utilizes solid excipients within a film-coated design engineered to control the rate at which the dose is absorbed. This controlled-release mechanism ensures the drug is delivered gradually over a prolonged period, helping to maintain stable concentrations of the active substance in the bloodstream throughout the day.


General Purpose of an Atypical Antipsychotic

The general therapeutic purpose of Serotiapine, driven by its action as a serotonin–dopamine antagonist, is to restore psychological stability and emotional balance. The medicine achieves this by adjusting the activity of key chemical messengers, specifically dopamine and serotonin, through receptor antagonism in the brain. The overall goal is to mitigate states of severe emotional imbalance, reduce mental agitation, and foster more coherent thought processes, thus working to establish a psychological equilibrium.

Regulatory References

  1. Quetiapine: MedlinePlus Drug Information

What side effects are possible with Serotiapine?

Possible Side Effects and Safety Information

Serotiapine's safety profile, as documented in regulatory sources (FDA, EMA), includes several serious warnings and potential adverse reactions requiring clinical monitoring.

Serious and Clinically Significant Risks

Serotiapine carries a Boxed Warning regarding Increased Mortality in Elderly Patients with Dementia-Related Psychosis; it is not approved for this condition. A second Boxed Warning notes an increased risk of Suicidal Thoughts and Behaviors in children, adolescents, and young adults when starting treatment for major depressive episodes in bipolar disorder.

Other serious risks include Neuroleptic Malignant Syndrome (NMS), Tardive Dyskinesia (TD), and Cerebrovascular Adverse Reactions (like stroke) in elderly patients with dementia. There is also a risk of Metabolic Changes, including hyperglycemia (high blood sugar, potentially leading to diabetes), dyslipidemia, and significant weight gain, necessitating regular monitoring of these parameters.

Common Adverse Reactions

The most frequently reported adverse reactions (classified as very common or common) are generally associated with the drug's effects on the central nervous and cardiovascular systems. These include somnolence (sleepiness), dizziness, dry mouth, constipation, asthenia (weakness), and orthostatic hypotension (a drop in blood pressure upon standing, which may lead to falls).

Population-Specific Safety Notes

  • Elderly: Increased risk for mortality, orthostatic hypotension, and cerebrovascular adverse events. Use requires caution, and a lower starting dose may be recommended.
  • Children and Adolescents: Higher incidence of certain effects like increased blood pressure, increased appetite, and elevations in the hormone prolactin have been observed compared to adults.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Serotiapine (Quetiapine) is documented in regulatory sources as potentially causing Central Nervous System (CNS) depression, which can range from profound drowsiness and somnolence to severe confusion and coma. The cardiovascular system is also commonly affected, exhibiting signs such as tachycardia (fast heartbeat) and hypotension (low blood pressure). The modified-release (XR) formulation may cause a delayed onset and prolonged duration of symptoms, which necessitates extended hospital monitoring.


Severe Manifestations and Risks

Regulatory documents report potential severe outcomes, including seizures, respiratory depression, and specific cardiac findings such as QTc interval prolongation. Ingestions by adolescents are noted to have an increased risk of toxicity severity.


Required Emergency Action

Immediate medical attention must be sought in all suspected overdose cases. Emergency services must be contacted immediately if the individual has collapsed, is unconscious, is having a seizure, or is experiencing trouble breathing.


Management and Antidote Status

No specific antidote is known for Serotiapine. Management is strictly symptomatic and supportive, including intensive care procedures to maintain the airway and provide necessary cardiovascular support. Gastrointestinal decontamination, such as the administration of activated charcoal, may be considered by healthcare professionals.

Therapeutic Uses of Serotiapine

What Serotiapine Treats: Main Uses and Benefits

Serotiapine (quetiapine) is commonly used across key domains involving severe mood and thought disruptions, providing support that helps ease overall symptom burden across key symptom domains.

This medication is applied across three primary areas: for managing Psychotic Disorders (like Schizophrenia), managing the extreme, episodic mood swings of Bipolar Disorder (including acute mania and depression), and as an adjunctive treatment in Major Depressive Disorder (MDD) where additional symptomatic support is needed.

Therapeutic Focus and Benefit

Serotiapine is relevant in conditions characterized by periods of heightened symptoms, helping to address symptom clusters that may become intense or disruptive. A primary benefit is the support it provides in addressing disordered thought processes and extreme emotional distress, which assists with maintaining functional stability. It is frequently applied in scenarios where additional management of discomfort is required, helping to maintain stability. This supports the patient during difficult episodes by easing extreme distress and contributes to easing discomfort during symptomatic periods.

“Serotiapine supports the patient during difficult episodes by easing extreme distress and contributing to easing discomfort during symptomatic periods.”


Quick Fact: Symptom Management

Quick Fact: Symptom Management for Psychotic, Manic, and Severe Depressive Symptoms in situations involving recurrent or episodic manifestations.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Serotiapine (quetiapine) eligibility is strictly defined by regulatory bodies based on age, physiological status, and contraindicating conditions.

Contraindicated Populations Use is contraindicated in patients with a known hypersensitivity to the drug or any component. It is also prohibited in elderly patients with dementia-related psychosis due to official warnings regarding an increased risk of mortality. Additionally, concurrent use with strong CYP3A4 inhibitors (such as certain antifungal or HIV medicines) is contraindicated.

Age-Related Eligibility Adults are eligible for all approved uses. Adolescents (10 to 17 years) are approved for specific indications like Schizophrenia or Bipolar Mania. However, some regulatory agencies do not recommend use for patients under 18 due to insufficient long-term data. The medicine is not approved for children under 10 years of age.

Condition-Specific Restrictions Use requires caution in patients with hepatic impairment (liver damage) as the drug’s clearance is reduced. Caution is also necessary for those with cardiovascular disease or a history of low white blood cell counts, requiring close monitoring. Renal impairment (kidney damage) does not typically necessitate adjustment. During pregnancy and lactation, use is conditional or not recommended, requiring a decision to discontinue the drug or nursing.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Serotiapine details specific constraints on its co-administration with other medications, primarily related to pharmacokinetic and pharmacodynamic effects.

Pharmacokinetic Interactions

The clearance of Serotiapine may be significantly impacted by medicines that affect the CYP3A4 enzyme system.

  • Strong CYP3A4 Inhibitors: These agents may decrease the drug's clearance, requiring that a lower dose of Serotiapine be considered to manage exposure.
  • Strong CYP3A4 Inducers: Medicines such as phenytoin and rifampin may increase the drug's clearance. This can necessitate a significant dose increase (up to 5-fold) for Serotiapine when the inducer is used as a chronic treatment for more than 7 to 14 days. Conversely, the Serotiapine dose must be reduced upon discontinuation of the strong inducer.

Pharmacodynamic Interactions

Co-administration with other medicines can result in additive effects or antagonism:

  • Antihypertensive Agents: Serotiapine may add to the hypotensive effects of these agents, increasing the potential for orthostatic hypotension. Use with caution is advised.
  • Levodopa and Dopamine Agents: Serotiapine may antagonize the effect of these medications.
  • Other Centrally Acting Drugs: Caution is generally advised when Serotiapine is used in combination with other medicines that affect the central nervous system.

Mechanism of Action

Serotiapine is a psychotropic agent that functions primarily as a mixed antagonist at several central nervous system (CNS) neurotransmitter receptors. Its primary biological targets include the serotonin 5-HT2A receptor and the dopamine D2 receptor. The drug exhibits a higher binding affinity for the 5-HT2A receptor relative to the D2 receptor.

Antagonism of the G protein-coupled D2 receptor in dopaminergic pathways, such as the mesolimbic and mesocortical systems, modulates adenylyl cyclase activity. Downstream of this interaction, there is a subsequent change in the intracellular concentration of the second messenger cyclic AMP (cAMP), thereby modifying protein kinase A (PKA) activity and its associated signaling cascades. The resulting system-level physiological consequence involves the modulation of monoaminergic neurotransmission across diverse brain regions, affecting neuronal excitation and inhibitory balance in both limbic and cortical structures. This alters the overall functional status of key neural circuits.

Dosage and Administration Information

How to Use Serotiapine

Serotiapine (Quetiapine Fumarate) is formulated primarily as an Extended-Release (XR) tablet for oral administration. The medicine is designed for once-daily dosing and should be administered in the evening, establishing a regular, predictable administration pattern.

Administration and Dosage Principles

The XR tablets must be swallowed whole and must not be split, chewed, or crushed, as this would disrupt the controlled-release mechanism of the formulation. In terms of timing, the dose should be taken without food or with a light meal (defined as approximately 300 calories).

Treatment is initiated with a low starting dose and requires a gradual daily titration over several days to safely reach the established maintenance dose range. This maintenance dose varies depending on the specific approved use, ranging from 150 mg to 800 mg per day. The maximum recommended daily dose for the most severe indications is 800 mg.

Population and Procedural Adjustments

Special dosing considerations apply to certain populations. For older adults (geriatric patients) and individuals with known hepatic impairment, established protocols indicate that a lower starting dose of 50 mg per day and a slower titration schedule are necessary.

Furthermore, the dose is subject to modification when the medicine is co-administered with other drugs that affect liver enzymes. The dose must be substantially reduced when taken with potent CYP3A4 inhibitors and may require a significant increase when used with potent CYP3A4 inducers. If therapy is interrupted for more than one week, the full initial titration schedule must be repeated when re-initiating treatment.

Recent Clinical Evidence

Serotiapine (quetiapine) has been the subject of clinical research focused on conditions characterized by fluctuating or episodic manifestations. The research base consists mainly of short-term, randomized clinical trials (RCTs). These studies were evaluated in specific patient populations and monitored changes compared to a placebo.


Evidence for Use in Schizophrenia

Research relied on short-term, placebo-controlled, randomized clinical trials. Studies monitored changes in positive and negative symptom severity and overall clinical severity over a limited time, typically around six weeks. Long-term research followed participants to explore the potential for symptom recurrence. However, there is limited information for long-term outcomes related to sustained daily functioning.


Evidence for Use in Bipolar Disorder

Serotiapine was evaluated in separate research programs focused on both acute episodes of mania and acute episodes of depression. Research on Acute Mania used RCTs in adult and adolescent participants that monitored outcomes capturing phases of heightened symptom activity. The evidence base for Bipolar Depression used short-term, placebo-controlled RCTs that examined outcomes related to functional imbalance, such as depressive symptom severity, in adults. Data for children and adolescents remain insufficient for the depressive phase.


Evidence for Use as Adjunctive Treatment in Major Depressive Disorder (MDD)

Research was evaluated as an add-on treatment for patients with MDD who did not have a sufficient response to standard antidepressants. These randomized controlled trials monitored changes in depressive symptom severity over defined time intervals, generally around eight weeks. The evidence derived from settings with varying symptom burdens is limited primarily to short-term outcomes.


Long-Term Studies, Special Populations, and Gaps

Long-term studies monitor rates of episodic recurrence, but long-term effects are not fully established regarding sustained functional recovery. Research has explored use in adolescents and older adults. Comparative evidence is lacking for certain uses, and evidence quality varies across studies, with limited information available for long-term outcomes that track sustained functioning.

Frequently Asked Questions (FAQ)

Common questions about Serotiapine (FAQ)

Q: What are the most common things people feel when they first start taking Serotiapine?

A: According to official regulatory adverse reaction reports, the most common feelings reported by people when starting treatment include somnolence (sleepiness), dizziness, dry mouth, and constipation. These are typically reported early in the course of treatment. The intensity of these effects may vary as the body adjusts to the medicine.


Q: What happens if I forget to take a Serotiapine dose?

A: Official prescribing information states that if a dose is missed, it should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped, and the regular schedule should be resumed. Official product information indicates that doses should not be doubled.


Q: Does Serotiapine interact with alcohol?

A: Regulatory documents indicate that alcohol consumption is recommended to be limited or avoided during treatment with Serotiapine. This is because alcohol can increase the risk and intensity of central nervous system (CNS) side effects. These additive effects may include increased drowsiness, dizziness, and difficulty with coordination.


Q: Can people who drive or operate heavy machinery use Serotiapine?

A: Official information notes that Serotiapine can potentially impair motor skills, judgment, and thinking due to common side effects like somnolence (sleepiness) and dizziness. Caution is advised regarding activities requiring mental alertness, consistent with the drug's label.


Q: What happens when people stop taking Serotiapine?

A: The drug is not intended to be stopped abruptly. Abrupt discontinuation, particularly after high doses, is associated with a risk of acute withdrawal symptoms. A gradual reduction of the dosage is described as the standard method for discontinuing treatment.


Q: What does the term 'Serotiapine withdrawal' refer to?

A: Withdrawal refers to temporary symptoms that may occur when the medicine is stopped too quickly. These effects, which official sources note are transient, may include difficulty sleeping (insomnia), dizziness, nausea, vomiting, and irritability. A gradual dose reduction is the described method to manage discontinuation.


Q: Are there different forms or versions of Serotiapine available?

A: Yes, Serotiapine is available in two main forms, according to official labeling. It comes as an immediate-release (IR) tablet, which is typically taken multiple times throughout the day, and an extended-release (XR) tablet, which is formulated for once-daily use.


Q: Why is this drug sometimes used with other medicines for treatment?

A: Official indications show that Serotiapine is approved for use as an adjunctive (or add-on) treatment for certain conditions, such as Major Depressive Disorder. This means it is used alongside another medicine for patients who have not had a sufficient response to their initial antidepressant therapy.


Q: How long does it usually take for Serotiapine to start working?

A: The exact time it takes to feel the full therapeutic effect is not specified in regulatory documents, but clinical trials often measure results over short timeframes, typically between six to eight weeks. The dosing schedule includes a titration period, a standard protocol to adjust the dose toward the target therapeutic level.


Q: Is Serotiapine known to cause weight gain or weight loss?

A: Regulatory warnings note that weight gain is a common adverse reaction and is part of the overall risk of metabolic changes. This risk necessitates regular monitoring of weight and related metabolic parameters. Weight loss is not consistently listed as a primary effect in the official product information.


Q: Does Serotiapine cause any effects on sex drive?

A: Official product information indicates that Serotiapine can affect sexual function. It may be associated with decreased libido (sex drive) and, in some cases, can cause elevated levels of the hormone prolactin (hyperprolactinemia). These effects may impact sexual health.


Q: Can Serotiapine be used during pregnancy or while breastfeeding?

A: Regulatory guidance on pregnancy states that the medicine should be used only if the potential benefit justifies the potential risk to the fetus. For women who are breastfeeding, a decision is needed to either discontinue nursing or discontinue the drug, based on the importance of the medicine to the mother.


Q: How long do the effects of Serotiapine last after stopping the treatment?

A: The drug’s elimination half-life, which is the time it takes for half of the dose to be cleared from the system, is approximately seven hours. However, the exact time required for all biological and therapeutic effects to fully subside after stopping treatment is highly variable and is not precisely defined in regulatory labeling.


Q: What should I know about Serotiapine if I have liver problems?

A: Official protocols state that individuals with known liver impairment (hepatic impairment) may require special dosing adjustments. Because the body's clearance of the medicine is reduced in these individuals, a lower starting dose and a slower dose titration schedule may be used.


Q: Can taking Serotiapine make existing problems like glaucoma worse?

A: Official warnings note that Serotiapine has anticholinergic properties that may potentially cause or worsen conditions like angle-closure glaucoma. Immediate medical attention is described as necessary if symptoms such as eye pain or blurred vision are experienced.


Q: Does Serotiapine need to be taken at a specific time of day?

A: The extended-release (XR) formulation is typically recommended for administration in the evening, according to official dosing guidelines. This timing is suggested partly because of the common side effect of sleepiness (somnolence) and helps maintain consistent drug levels during the day.


Q: Can Serotiapine be used alongside non-prescription allergy medicines?

A: Regulatory documents advise caution when Serotiapine is used with other medicines that affect the central nervous system (CNS). This includes certain non-prescription allergy drugs. Using these together could result in additive CNS depressant effects, such as increased sedation or drowsiness.


Q: Why do some people experience dry mouth or blurred vision with Serotiapine?

A: Official medical literature describes these effects as being related to the drug's activity at specific cell receptors in the body, known as muscarinic acetylcholine receptors. This action, categorized as anticholinergic, is what causes common side effects like dry mouth and blurred vision.


Q: Can I take Serotiapine if I have a history of seizures?

A: Official warnings state that the medicine should be used with caution in individuals who have a history of seizures. This is because Serotiapine, like other similar drugs, may potentially lower the seizure threshold in some patients.


Q: What is the general consensus on Serotiapine's safety profile?

A: According to regulatory documents, the safety profile includes both commonly reported side effects, such as dry mouth and sleepiness, and several serious warnings. These serious risks, which require clinical monitoring, include metabolic changes and a Boxed Warning regarding increased mortality risk in specific elderly patients.


Q: Can Serotiapine affect my ability to concentrate or focus?

A: Official warnings indicate that Serotiapine has the potential to cause impairment in both cognitive (thinking) and motor skills. This impairment may manifest as a reduced ability to concentrate or focus. Caution is advised when performing tasks that require full mental alertness.


Q: Are there specific symptoms that require immediate medical attention while on Serotiapine?

A: Official warnings highlight symptoms of serious adverse events that require immediate evaluation. These include signs of Neuroleptic Malignant Syndrome (e.g., high fever, severe muscle stiffness), Tardive Dyskinesia (e.g., uncontrollable body movements), or any new or worsening suicidal thoughts.

How should Serotiapine be stored and disposed of?

How to Store and Dispose of Serotiapine

Official regulatory documents define strict conditions for the storage and disposal of Serotiapine (quetiapine) tablets to preserve the product's stability and ensure safety.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F).
Container Must be kept in the original container and maintained tightly closed and protected from excessive moisture.
Safety Store strictly out of the reach and sight of children.

Disposal Instructions

Unused or expired Serotiapine should be disposed of in alignment with local guidelines for pharmaceutical waste. The preferred method is to utilize a medicine take-back program. If a program is unavailable, official guidance permits mixing the tablets with an undesirable substance in a sealed container before disposal with household trash. Proper disposal ensures environmental protection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Serotiapine found in:

A-Z Index: